Asked by: Richard Holden (Conservative - Basildon and Billericay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what guidance NHS England has issued to maternity services on when and how pregnant patients are informed of their BMI, including requirements on explaining associated clinical risks and available support.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence provides detailed guidelines for maternity service staff in relation to body mass index (BMI) and managing weight during pregnancy.
This includes the Antenatal Care Guidance which specifies that women should be offered measurement of height and weight, including a calculation of BMI, at their antenatal booking appointment. This should also include an explanation of BMI’s relevance to pregnancy, as well as associated risks and available support. This guidance is available at the following link:
https://www.nice.org.uk/guidance/ng201
In addition, the Overweight and Obesity Management Guidance specifies that for women with a BMI of 40 kilogram per meter squared of height or above, this discussion should include the option of referral to a specialist obesity service or specialist practitioner for tailored advice and support during pregnancy. This guidance is available at the following link:
https://www.nice.org.uk/guidance/ng247
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the abolition of NHS England on the commissioning, oversight and consistency of access to weight management services across England.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service and local government provide a range of weight management services. This includes behaviour change support such as the NHS Digital Weight Management Programme, intensive treatments like very low-calorie diets, pharmaceutical treatments, and bariatric surgery. NHS integrated care boards (ICBs) are responsible for arranging the provision of health services, such as specialist weight management services, within their area, in line with local population need, and taking account of relevant guidance.
NHS England will continue to carry out its existing responsibilities and statutory functions during the transition period following the Government’s decision to abolish the organisation. This includes commissioning the NHS Digital Weight Management Programme, oversight of NHS weight management services, and providing guidance, clinical leadership, and performance oversight of ICBs, while the Government brings forward legislation to amend the Department’s responsibilities.
Work is progressing at pace to develop the design and operating model for the new integrated organisation, and to plan for the smooth transfer of people, functions, and responsibilities. It is only right that with such significant reform, we commit to carefully assessing and understanding the potential impacts, as is due process. These ongoing assessments will inform our programme as appropriate.
Until the transfer of its functions, NHS England will continue to work with ICBs and providers to support the continuity of multidisciplinary provision and workforce capacity, and access to services across England.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, where responsibility for national leadership and accountability for obesity and weight management services will sit following the abolition of NHS England; and what steps he is taking to prevent regional variation in access to those services.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service and local government provide a range of weight management services. This includes behaviour change support such as the NHS Digital Weight Management Programme, intensive treatments like very low-calorie diets, pharmaceutical treatments, and bariatric surgery. NHS integrated care boards (ICBs) are responsible for arranging the provision of health services, such as specialist weight management services, within their area, in line with local population need, and taking account of relevant guidance.
NHS England will continue to carry out its existing responsibilities and statutory functions during the transition period following the Government’s decision to abolish the organisation. This includes commissioning the NHS Digital Weight Management Programme, oversight of NHS weight management services, and providing guidance, clinical leadership, and performance oversight of ICBs, while the Government brings forward legislation to amend the Department’s responsibilities.
Work is progressing at pace to develop the design and operating model for the new integrated organisation, and to plan for the smooth transfer of people, functions, and responsibilities. It is only right that with such significant reform, we commit to carefully assessing and understanding the potential impacts, as is due process. These ongoing assessments will inform our programme as appropriate.
Until the transfer of its functions, NHS England will continue to work with ICBs and providers to support the continuity of multidisciplinary provision and workforce capacity, and access to services across England.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure continuity of specialist weight management services, including workforce capacity and multidisciplinary provision, during the transition following the abolition of NHS England.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service and local government provide a range of weight management services. This includes behaviour change support such as the NHS Digital Weight Management Programme, intensive treatments like very low-calorie diets, pharmaceutical treatments, and bariatric surgery. NHS integrated care boards (ICBs) are responsible for arranging the provision of health services, such as specialist weight management services, within their area, in line with local population need, and taking account of relevant guidance.
NHS England will continue to carry out its existing responsibilities and statutory functions during the transition period following the Government’s decision to abolish the organisation. This includes commissioning the NHS Digital Weight Management Programme, oversight of NHS weight management services, and providing guidance, clinical leadership, and performance oversight of ICBs, while the Government brings forward legislation to amend the Department’s responsibilities.
Work is progressing at pace to develop the design and operating model for the new integrated organisation, and to plan for the smooth transfer of people, functions, and responsibilities. It is only right that with such significant reform, we commit to carefully assessing and understanding the potential impacts, as is due process. These ongoing assessments will inform our programme as appropriate.
Until the transfer of its functions, NHS England will continue to work with ICBs and providers to support the continuity of multidisciplinary provision and workforce capacity, and access to services across England.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to develop a long-term strategy alongside medical professionals to ensure sustainable funding for obesity services, including prevention, behavioural and psychological programmes, and alongside clinical treatments.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service and local government provide a range of obesity services, from universal prevention initiatives to targeted interventions, including behaviour change programmes, digital tools and apps, and specialist services for people living with severe obesity and related conditions. These services support individuals at every stage to achieve and maintain a healthier weight.
Commissioning and funding decisions for obesity services are made locally by local authorities and NHS organisations in line with assessed population needs and available budgets. The Department works with these partners and NHS England to provide national policy direction, to support effective and sustainable service models and to introduce digital behavioural programmes.
NHS England is supporting integrated care boards (ICBs) to deliver a phased roll‑out of tirzepatide for the treatment of obesity. They have provided funding and guidance to ICBs and established a national wraparound support service for patients receiving these treatments, covering diet, physical activity, and behaviour change.
As set out in our 10-Year Health Plan for England, we are taking decisive action on the obesity crisis, including restricting junk food advertising to children, and setting healthy sales reporting and targets for large food businesses.
Whilst we recognise that prevention will always be better than a cure, we also need to support those already living with obesity. We have committed to doubling the number of people able to access the NHS Digital Weight Management Programme and to expand access to the newest obesity medicines.
Asked by: Lord Bourne of Aberystwyth (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what consideration they are giving to alternatives to weight loss drugs in appropriate cases, in particular (1) taxation of unhealthy food, and (2) promotion of exercise.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to tackling the root causes of obesity, shifting the focus from treatment to prevention. As part of our 10-Year Health Plan, we’re improving diets, increasing physical activity, and creating healthier environments so fewer people reach the point of needing treatment. This includes requiring all large food businesses to report against standardised metrics on healthier food sales, setting full transparency and accountability around the food that businesses are selling, and encouraging healthier products. We will also be updating the standards behind the advertising and promotions restrictions on ‘less healthy’ food and drink to bring these restrictions in line with the latest dietary advice and increase their health impact.
There currently isn’t a tax on less healthy food, although the Soft Drinks Industry Levy (SDIL) has been in place since 2018 and applies to manufacturers and importers of pre-packed added sugar soft drinks that contain five grams of total sugar per 100 millilitres or more. However, in the 2025 Autumn Budget, my Rt. Hon. Friend, the Chancellor of the Exchequer, announced the extension of the SDIL to pre-packed milk-based and milk substitutes, including soya, oat, and almond milk, among others, and a lowering of the lowest sugar threshold at which the levy applies to 4.5 grams of sugar per 100 millilitres. These measures will come into effect on 1 January 2028. The Government keeps all taxes under regular review.
We also need to support those already living with obesity. The National Health Service and local government provide a range of services to support people living with overweight and obesity to reach a healthier weight. For eligible individuals, this includes the option of being prescribed weight loss medicines, but there are also other weight management services available, including behavioural support and surgery.
The Government recognises that, coupled with interventions such as promoting a healthy diet, physical activity can help with the maintenance of a healthier weight. The national movement campaign announced in the 10-Year Health Plan will get millions moving more and the development of a new school sport partnerships network will provide more opportunities for the least active children to reap the benefits of movement.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many men have been prescribed GLP1 weight-loss injections on the NHS in the last 12 months.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Business Services Authority holds data on drugs that have been submitted for reimbursement from English dispensing contractors in community settings. Patient information has been captured where possible. No data about the clinical indication for a prescription can be captured.
The following table provides the total number of identified patients who were dispensed injectable medicines listed in the NHS Obesity Guidance and licenced for the use of weight loss management, between December 2024 and November 2025, regardless of where prescribed:
Products | Male patients | Female patients |
Injectable weight loss medication | 146,900 | 163,400 |
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many women have been prescribed GLP1 weight-loss injections on the NHS in the last year.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Business Services Authority holds data on drugs that have been submitted for reimbursement from English dispensing contractors in community settings. Patient information has been captured where possible. No data about the clinical indication for a prescription can be captured.
The following table provides the total number of identified patients who were dispensed injectable medicines listed in the NHS Obesity Guidance and licenced for the use of weight loss management, between December 2024 and November 2025, regardless of where prescribed:
Products | Male patients | Female patients |
Injectable weight loss medication | 146,900 | 163,400 |
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people have been referred to Weightloss clinics within the last year.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service and local government provide a range of services to help people living with overweight and obesity to manage their weight.
Integrated care boards are responsible for commissioning health services within their area in line with local population need and taking account of relevant guidance. This includes specialist weight management services, or weight loss clinics, for those living with severe obesity and associated health conditions.
The National Obesity Audit (NOA) aims to bring together existing comparable data from the different types of weight management services across England in order to drive improvement for the benefit of those living with overweight and obesity. Responsibility for the management and collection of referral data sits at a local system level, and not all providers of weight management services are submitting data into the NOA at present. It is therefore not possible to state how many people have been referred to weight loss clinics within the last year.
NHS England continues to develop the NOA with the aim of ensuring it will provide a comprehensive picture of activity, access to services, and health outcomes of patients using weight management services across England.
Asked by: Tom Morrison (Liberal Democrat - Cheadle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment they have made of variations in access to Tirzepatide (Mounjaro) across Integrated Care Boards; and what steps they are taking to ensure consistency in prescribing for eligible patients.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Tirzepatide, brand name Mounjaro, is recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of both type 2 diabetes and obesity.
Integrated care boards (ICBs) are legally required to fund NICE-recommended medicines, including obesity treatments, within three months of final approval. NICE granted a phased rollout of tirzepatide for obesity to manage National Health Service resources and establish new care pathways. ICBs have been legally required to fund tirzepatide for obesity so that prescribers can offer the treatment to eligible patients in specialist weight management services since March 2025 and in primary care from 23 June 2025. NHS England is providing support for ICBs, including providing:
- additional funding to support the delivery of services within primary care and the cost of obesity medicines in line with interim commissioning guidance; and
- a centrally funded wraparound care service ‘Healthier You: Behavioural Support for Obesity Prescribing’ for primary care to refer patients to.
We do not hold information on whether each ICB provides access to specific medicines in its locality. ICBs are responsible for ensuring they meet their legal duties, including making funding for NICE-recommended medicines available.